Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-14 Purchase | 2024-06-17 09:26 am | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,250 | $20.03 | $25,037 | 52,623 (Direct) | View |
| 2023-06-13 Sale | 2023-06-14 4:20 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 577 | $22.31 | $12,873 | 2,628 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 1:23 pm | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 4,617 | $2.11 | $9,742 | 141,726 (Direct) | View |
| 2021-12-16 Sale | 2021-12-17 09:27 am | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 580 | $1.64 | $951 | 89,613 (Direct) | View |
| 2021-09-16 Sale | 2021-09-17 1:53 pm | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 578 | $2.789 | $1,612 | 90,193 (Direct) | View |
| 2021-06-17 Sale | 2021-06-17 6:35 pm | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 576 | $3.73 | $2,148 | 90,771 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 6:11 pm | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 2,304 | $3.92 | $9,032 | 91,347 (Direct) | View |
| 2020-09-23 Purchase | 2020-09-23 4:47 pm | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 2,500 | $3.897 | $9,743 | 9,751 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Other | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,183 | $17.42 | 123,418 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 46,700 | $0 | 123,418 (Direct) | View |
| 2023-07-31 Other | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 862 | $18.12 | 123,418 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A 2034-02-07 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 70,000 | $22.28 | 123,418 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:00 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 110,000 | $28.55 | 110,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 4:12 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 3,205 | $0 | 233,205 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 4:12 pm | N/A 2032-06-13 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 230,000 | $15.6 | 233,205 (Direct) | View |
| 2022-01-11 Option Award | 2022-01-12 4:02 pm | N/A 2032-01-11 | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 208,010 | $0 | 297,623 (Direct) | View |
| 2020-03-06 Option Award(A) | 2021-03-17 6:04 pm | N/A N/A | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 30,567 | $0 | 83,178 (Direct) | View |
| 2020-03-06 Option Award(A) | 2021-03-17 6:04 pm | N/A 2030-03-06 | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 45,850 | $5.41 | 83,178 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 5:19 pm | N/A N/A | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 53,333 | $0 | 143,084 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 5:19 pm | N/A 2031-03-04 | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 80,000 | $3.51 | 143,084 (Direct) | View |
| 2020-03-06 Option Award | 2020-03-09 07:06 am | N/A N/A | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 30,567 | $0 | 76,417 (Direct) | View |
| 2020-03-06 Option Award | 2020-03-09 07:06 am | N/A 2030-03-06 | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 45,850 | $5.41 | 76,417 (Direct) | View |
| 2019-12-31 Ownership | 2020-01-16 4:11 pm | N/A N/A | OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer | 2,695 | $6.13 | 6,761 (Direct) | View |